Challenges in Matrix Metalloproteinases Inhibition.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
05 05 2020
Historique:
received: 09 04 2020
revised: 27 04 2020
accepted: 30 04 2020
entrez: 9 5 2020
pubmed: 10 5 2020
medline: 10 4 2021
Statut: epublish

Résumé

Matrix metalloproteinases are enzymes that degrade the extracellular matrix. They have different substrates but similar structural organization. Matrix metalloproteinases are involved in many physiological and pathological processes and there is a need to develop inhibitors for these enzymes in order to modulate the degradation of the extracellular matrix (ECM). There exist two classes of inhibitors: endogenous and synthetics. The development of synthetic inhibitors remains a great challenge due to the low selectivity and specificity, side effects in clinical trials, and instability. An extensive review of currently reported synthetic inhibitors and description of their properties is presented.

Identifiants

pubmed: 32380782
pii: biom10050717
doi: 10.3390/biom10050717
pmc: PMC7277161
pii:
doi:

Substances chimiques

Matrix Metalloproteinase Inhibitors 0
Tissue Inhibitor of Metalloproteinases 0
Matrix Metalloproteinases EC 3.4.24.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fundação para a Ciência e Tecnologia
ID : A MOLECULAR VIEW OF DENTAL RESTORATION, PTDC/SAU-BMA/122444/2010
Pays : International

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Bioorg Med Chem Lett. 2003 Sep 1;13(17):2843-6
pubmed: 14611841
J Med Chem. 2006 Feb 9;49(3):923-31
pubmed: 16451058
Drug Discov Today. 2020 Jan;25(1):38-57
pubmed: 31513929
Molecules. 2019 Aug 16;24(16):
pubmed: 31426440
Chem Rev. 1997 Aug 5;97(5):1359-1472
pubmed: 11851455
Pharm Res. 1991 Dec;8(12):1453-60
pubmed: 1808606
J Med Chem. 1993 Dec 24;36(26):4293-301
pubmed: 8277511
PLoS One. 2017 Apr 3;12(4):e0174853
pubmed: 28369077
Bioorg Med Chem Lett. 1998 Aug 18;8(16):2087-92
pubmed: 9873491
J Dent Res. 2011 Aug;90(8):953-68
pubmed: 21220360
Biochemistry. 1986 Sep 9;25(18):5189-95
pubmed: 3021211
Bioorg Med Chem Lett. 2005 Jun 2;15(11):2808-11
pubmed: 15911259
Cancer Res. 1988 Jun 15;48(12):3307-12
pubmed: 2836052
Int J Dev Biol. 2004;48(5-6):411-24
pubmed: 15349816
Biochimie. 2005 Mar-Apr;87(3-4):249-63
pubmed: 15781312
Anal Chem. 2005 Apr 1;77(7):2116-24
pubmed: 15801745
J Biol Chem. 2005 Oct 7;280(40):33992-4002
pubmed: 16046398
Biochim Biophys Acta. 2010 Jan;1803(1):72-94
pubmed: 19712708
Cardiovasc Res. 2006 Feb 15;69(3):562-73
pubmed: 16405877
Comb Chem High Throughput Screen. 2006 Sep;9(8):599-611
pubmed: 17017880
Mol Biotechnol. 2003 Nov;25(3):241-66
pubmed: 14668538
J Enzyme Inhib. 1987;2(1):1-22
pubmed: 2854154
Genome Biol. 2011 Nov 11;12(11):233
pubmed: 22078297
Amino Acids. 2011 Jul;41(2):271-90
pubmed: 20640864
Int J Cancer. 1995 Mar 29;61(1):121-9
pubmed: 7705924
Biochem J. 2005 Dec 15;392(Pt 3):527-36
pubmed: 16026329
Prog Mol Biol Transl Sci. 2017;147:1-73
pubmed: 28413025
FASEB J. 2004 Apr;18(6):690-2
pubmed: 14766804
Int J Mol Sci. 2019 Aug 07;20(16):
pubmed: 31394726
Crit Rev Biochem Mol Biol. 2007 May-Jun;42(3):113-85
pubmed: 17562450
J Appl Oral Sci. 2019 Sep 09;27:e20180596
pubmed: 31508793
Bioorg Med Chem. 2007 Mar 15;15(6):2223-68
pubmed: 17275314
Eur Respir J. 2011 Nov;38(5):1200-14
pubmed: 21659416
Semin Cell Dev Biol. 2008 Feb;19(1):61-8
pubmed: 17693104
Nat Rev Drug Discov. 2007 Jun;6(6):480-98
pubmed: 17541420
Chem Pharm Bull (Tokyo). 1995 Nov;43(11):1883-93
pubmed: 8575029
Bioorg Med Chem Lett. 1999 Jan 18;9(2):127-32
pubmed: 10021913
Curr Med Chem. 2008;15(22):2192-222
pubmed: 18781944
J Med Chem. 1998 Jan 29;41(3):339-45
pubmed: 9464365
Prog Histochem Cytochem. 2012 Mar;47(1):27-58
pubmed: 22226510
Rom J Morphol Embryol. 2007;48(4):323-34
pubmed: 18060181
J Med Chem. 1999 Jan 14;42(1):87-94
pubmed: 9888835
Pharmacol Ther. 2020 Mar;207:107465
pubmed: 31863819
Biochim Biophys Acta. 2010 Jan;1803(1):20-8
pubmed: 19374923
Cell Mol Life Sci. 2019 Oct 23;:
pubmed: 31642940
Biol Chem. 1997 Dec;378(12):1475-80
pubmed: 9461346
Bioorg Med Chem Lett. 1998 May 19;8(10):1157-62
pubmed: 9871727
Arch Biochem Biophys. 1997 Nov 1;347(1):62-8
pubmed: 9344465
Biochimie. 2005 Mar-Apr;87(3-4):393-402
pubmed: 15781327
J Biol Chem. 2002 Mar 29;277(13):11201-7
pubmed: 11790786
Circ Res. 2003 May 2;92(8):827-39
pubmed: 12730128
Cells. 2019 Aug 27;8(9):
pubmed: 31461880
Chemistry. 2019 Jun 18;25(34):7960-7980
pubmed: 30720221
Crit Rev Biochem Mol Biol. 2010 Oct;45(5):351-423
pubmed: 20812779
J Med Chem. 2017 May 11;60(9):3814-3827
pubmed: 28394608
Biochem Biophys Res Commun. 1986 Apr 14;136(1):390-5
pubmed: 3010973
Curr Pharm Des. 2007;13(20):2087-100
pubmed: 17627541
J Med Chem. 2003 Jul 31;46(16):3514-25
pubmed: 12877590
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):2043-2055
pubmed: 28526562
Bioorg Med Chem. 2008 Oct 1;16(19):8781-94
pubmed: 18790648
Bioorg Med Chem Lett. 2000 Dec 18;10(24):2815-7
pubmed: 11133099
J Med Chem. 2004 Jan 15;47(2):325-36
pubmed: 14711305
J Med Chem. 1998 May 21;41(11):1745-8
pubmed: 9599225
J Med Chem. 1997 Aug 1;40(16):2525-32
pubmed: 9258358
Mol Aspects Med. 2008 Oct;29(5):290-308
pubmed: 18619669
Curr Med Chem. 2019;26(15):2609-2633
pubmed: 29589527
J Med Chem. 1993 Dec 10;36(25):4030-9
pubmed: 8258825
Bioorg Med Chem. 1997 Apr;5(4):765-78
pubmed: 9158875
Prog Mol Biol Transl Sci. 2017;148:355-420
pubmed: 28662828
Chem Rev. 1999 Sep 8;99(9):2735-76
pubmed: 11749499

Auteurs

Helena Laronha (H)

Centro de Investigação Interdisciplinar Egas Moniz, Instituto Universitário Egas Moniz, 2829-511 Caparica, Portugal.
UCIBIO and LAQV, Requimte, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.

Inês Carpinteiro (I)

Centro de Investigação Interdisciplinar Egas Moniz, Instituto Universitário Egas Moniz, 2829-511 Caparica, Portugal.

Jaime Portugal (J)

Faculdade de Medicina Dentária Universidade de Lisboa, 1649-003 Lisboa, Portugal.

Ana Azul (A)

Centro de Investigação Interdisciplinar Egas Moniz, Instituto Universitário Egas Moniz, 2829-511 Caparica, Portugal.

Mário Polido (M)

Centro de Investigação Interdisciplinar Egas Moniz, Instituto Universitário Egas Moniz, 2829-511 Caparica, Portugal.

Krasimira T Petrova (KT)

UCIBIO and LAQV, Requimte, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.

Madalena Salema-Oom (M)

Centro de Investigação Interdisciplinar Egas Moniz, Instituto Universitário Egas Moniz, 2829-511 Caparica, Portugal.
UCIBIO and LAQV, Requimte, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.

Jorge Caldeira (J)

Centro de Investigação Interdisciplinar Egas Moniz, Instituto Universitário Egas Moniz, 2829-511 Caparica, Portugal.
UCIBIO and LAQV, Requimte, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH